ArticleRSC advances2026
New biosensor for the early detection of tPSA in the serum of prostate cancer patients using a Tb-anthracene-9-carboxaldehyde complex embedded in a modified cellulose polymer thin film.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study reports the development and validation of a novel optical biosensor for the early detection of total prostate-specific antigen (tPSA) in serum samples from prostate cancer patients, utilizing a terbium-anthracene-9-carboxaldehyde (Tb-A9C) complex embedded within an epoxy-functionalized carboxymethyl cellulose (CMC) polymer thin film. The sensor was systematically optimized by investigating solvent effects and metal-to-ligand molar ratios, with dimethyl sulfoxide (DMSO) and a 1 : 1 (Tb : A9C) stoichiometry identified as optimal conditions yielding maximum luminescence intensity at 545 nm. Surface characterization
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.